Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Latest therapies for bipolar disorder: Looking beyond lithium
Joseph F. Goldberg
, Leslie Citrome
Research output
:
Contribution to journal
›
Article
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Latest therapies for bipolar disorder: Looking beyond lithium'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Bipolar Disorder
100%
Olanzapine
100%
Beyond Lithium
100%
Lithium
66%
FDA-approved Drugs
66%
Antipsychotics
33%
Combination Therapy
33%
Quetiapine
33%
Effective Treatment
33%
Adjunctive Therapy
33%
Maintenance Treatment
33%
Anticonvulsant
33%
Rapid Cycling
33%
Risperidone
33%
Mania
33%
Fluoxetine
33%
Suicide Prevention
33%
Off-label Use
33%
Divalproex
33%
Lamotrigine
33%
Combination Medication
33%
Residual Symptoms
33%
Acute Mania
33%
Mixed State
33%
Acute Bipolar Depression
33%
Pharmacology, Toxicology and Pharmaceutical Science
Bipolar Disorder
100%
Olanzapine
100%
Combination Drug
33%
Anticonvulsive Agent
33%
Combination Therapy
33%
Quetiapine
33%
Fluoxetine
33%
Bipolar Depression
33%
Lamictal
33%
Risperidone
33%
Valproate Semisodium
33%
Off-Label Use
33%
Diseases
33%